Reviva Historical Income Statement
| RVPH Stock | USD 1.53 0.10 6.99% |
Historical analysis of Reviva Pharmaceuticals income statement accounts such as Interest Income of 523.9 K, Depreciation And Amortization of 212.7 K, Selling General Administrative of 4.6 M or Total Revenue of 0.0 can show how well Reviva Pharmaceuticals Holdings performed in making a profits. Evaluating Reviva Pharmaceuticals income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Reviva Pharmaceuticals's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Reviva Pharmaceuticals latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Reviva Pharmaceuticals is a good buy for the upcoming year.
Reviva |
About Reviva Income Statement Analysis
Reviva Pharmaceuticals Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Reviva Pharmaceuticals shareholders. The income statement also shows Reviva investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Reviva Pharmaceuticals Income Statement Chart
Reviva Pharmaceuticals Holdings Income Statement is one of the three primary financial statements used for reporting Reviva's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Reviva Pharmaceuticals revenue and expense. Reviva Pharmaceuticals Income Statement primarily focuses on the company's revenues and expenses during a particular period.
As of now, Reviva Pharmaceuticals' Other Operating Expenses is increasing as compared to previous years. The Reviva Pharmaceuticals' current Research Development is estimated to increase to about 33 M, while Interest Expense is projected to decrease to under 156.3 K. Add Fundamental
Tax Provision
The amount set aside by a company to cover any estimated taxes for the current period. It reflects the company's expected tax liabilities.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Reviva Pharmaceuticals. It is also known as Reviva Pharmaceuticals overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Income Before Tax
Income Before Tax which can also be referred as pre-tax income is reported on Reviva Pharmaceuticals income statement and is an important metric when analyzing Reviva Pharmaceuticals profitability. Accounting techniques because taxes can be complex, and not perfectly consistent from one company to company, an analyst may use pre-tax income as a more stable measure of profitability.Most accounts from Reviva Pharmaceuticals' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Reviva Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Reviva Pharmaceuticals Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. As of now, Reviva Pharmaceuticals' Other Operating Expenses is increasing as compared to previous years. The Reviva Pharmaceuticals' current Research Development is estimated to increase to about 33 M, while Interest Expense is projected to decrease to under 156.3 K.
| 2021 | 2022 | 2023 | 2024 (projected) | Tax Provision | 6.0K | 20.8K | 16.9K | 10.0K | Income Tax Expense | 6.0K | 20.8K | 23.9K | 25.1K |
Reviva Pharmaceuticals income statement Correlations
Click cells to compare fundamentals
Reviva Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Reviva Pharmaceuticals income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Interest Expense | 469.4K | 1.5M | 2.4K | 182.8K | 164.5K | 156.3K | |
| Ebit | (376.9K) | (2.4M) | (10.1M) | (24.3M) | (21.9M) | (20.8M) | |
| Net Income Applicable To Common Shares | (846.8K) | (3.8M) | (8.5M) | (24.3M) | (21.9M) | (20.8M) |
Currently Active Assets on Macroaxis
When determining whether Reviva Pharmaceuticals is a strong investment it is important to analyze Reviva Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Reviva Pharmaceuticals' future performance. For an informed investment choice regarding Reviva Stock, refer to the following important reports:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Reviva Pharmaceuticals Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Complementary Tools for Reviva Stock analysis
When running Reviva Pharmaceuticals' price analysis, check to measure Reviva Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Reviva Pharmaceuticals is operating at the current time. Most of Reviva Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Reviva Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Reviva Pharmaceuticals' price. Additionally, you may evaluate how the addition of Reviva Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
Is Reviva Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Reviva Pharmaceuticals. If investors know Reviva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Reviva Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.43) | Return On Assets (1.16) | Return On Equity (5.56) |
The market value of Reviva Pharmaceuticals is measured differently than its book value, which is the value of Reviva that is recorded on the company's balance sheet. Investors also form their own opinion of Reviva Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Reviva Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Reviva Pharmaceuticals' market value can be influenced by many factors that don't directly affect Reviva Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Reviva Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Reviva Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Reviva Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.